Citations (85)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Jiehong Kong & Weipeng Wang. (2020) A Systemic Review on the Regulatory Roles of miR-34a in Gastrointestinal Cancer. OncoTargets and Therapy 13, pages 2855-2872.
Read now
Read now
Bin Bao, Aamir Ahmad, Yiwei Li, Asfar S Azmi, Shadan Ali, Sanjeev Banerjee, Dejuan Kong & Fazlul H Sarkar. (2012) Targeting CSCs within the tumor microenvironment for cancer therapy: a potential role of mesenchymal stem cells. Expert Opinion on Therapeutic Targets 16:10, pages 1041-1054.
Read now
Read now
Adam E Frampton, Jonathan Krell, Jimmy Jacob, Justin Stebbing, Long R Jiao & Leandro Castellano. (2011) microRNAs as markers of survival and chemoresistance in pancreatic ductal adenocarcinoma. Expert Review of Anticancer Therapy 11:12, pages 1837-1842.
Read now
Read now
Articles from other publishers (82)
Harald Schuhwerk & Thomas Brabletz. (2023) Mutual regulation of TGFβ-induced oncogenic EMT, cell cycle progression and the DDR. Seminars in Cancer Biology 97, pages 86-103.
Crossref
Crossref
Małgorzata Kozłowska & Agnieszka Śliwińska. (2023) The Link between Diabetes, Pancreatic Tumors, and miRNAs—New Players for Diagnosis and Therapy?. International Journal of Molecular Sciences 24:12, pages 10252.
Crossref
Crossref
Fiona O’Neill, Taylor-Jade Allen-Coyle, Sandra Roche, Justine Meiller, Neil T. Conlon, Niall Swan, Robert M. Straubinger, Justin Geoghegan, Ninfa L. Straubinger, Kevin Conlon, Ray McDermott, Finbarr O’Sullivan, Michael Henry, Paula Meleady, Gerard McVey, Robert O’Connor, Michael Moriarty & Martin Clynes. (2023) Alteration in Levels of Specific miRNAs and Their Potential Protein Targets between Human Pancreatic Cancer Samples, Adjacent Normal Tissue, and Xenografts Derived from These Tumors. Life 13:3, pages 608.
Crossref
Crossref
Moumita Mukherjee, Satyajit Ghosh & Srikanta Goswami. (2022) Investigating the interference of single nucleotide polymorphisms with miRNA mediated gene regulation in pancreatic ductal adenocarcinoma: An in silico approach. Gene 819, pages 146259.
Crossref
Crossref
Abolfazl Akbari, Meghdad Sedaghat, Javad Heshmati, Seidamir Pasha Tabaeian, Sadegh Dehghani, Ana Beatriz Pizarro, Zahra Rostami & Shahram Agah. (2021) Molecular mechanisms underlying curcumin-mediated microRNA regulation in carcinogenesis; Focused on gastrointestinal cancers. Biomedicine & Pharmacotherapy 141, pages 111849.
Crossref
Crossref
Małgorzata Guz, Witold Jeleniewicz, Anna Malm & Izabela Korona-Glowniak. (2021) A Crosstalk between Diet, Microbiome and microRNA in Epigenetic Regulation of Colorectal Cancer. Nutrients 13:7, pages 2428.
Crossref
Crossref
Ha Thi Nguyen, Salah Eddine Oussama Kacimi, Truc Ly Nguyen, Kamrul Hassan Suman, Roselyn Lemus-Martin, Humaira Saleem & Duy Ngoc Do. (2021) MiR-21 in the Cancers of the Digestive System and Its Potential Role as a Diagnostic, Predictive, and Therapeutic Biomarker. Biology 10:5, pages 417.
Crossref
Crossref
Shaw M. Akula, Peter P. Ruvolo & James A. McCubrey. (2020) TP53/miR-34a-associated signaling targets SERPINE1 expression in human pancreatic cancer. Aging 12:3, pages 2777-2797.
Crossref
Crossref
Bishnupriya Chhatriya, Moumita Mukherjee, Sukanta Ray, Piyali Sarkar, Shatakshee Chatterjee, Debashis Nath, Kshaunish Das & Srikanta Goswami. (2019) Comparison of tumour and serum specific microRNA changes dissecting their role in pancreatic ductal adenocarcinoma: a meta-analysis. BMC Cancer 19:1.
Crossref
Crossref
Shen, Pu, Zheng, Ma, Qin, Jiang & Li. (2019) Differentially Expressed microRNAs in MIA PaCa-2 and PANC-1 Pancreas Ductal Adenocarcinoma Cell Lines are Involved in Cancer Stem Cell Regulation. International Journal of Molecular Sciences 20:18, pages 4473.
Crossref
Crossref
Zamira Vanessa Diaz-Riascos, Mireia M. Ginesta, Joan Fabregat, Teresa Serrano, Juli Busquets, Louis Buscail, Pierre Cordelier & Gabriel Capellá. (2019) Expression and Role of MicroRNAs from the miR-200 Family in the Tumor Formation and Metastatic Propensity of Pancreatic Cancer. Molecular Therapy - Nucleic Acids 17, pages 491-503.
Crossref
Crossref
Alia Abukiwan & Martin R. Berger. 2019. DNA Repair- An Update. DNA Repair- An Update.
Lei Li, Shan Wang, Hongyan Li, Jipeng Wan, Qian Zhou, Yu Zhou & Chunhua Zhang. (2018) microRNA‐96 protects pancreatic β‐cell function by targeting PAK1 in gestational diabetes mellitus. BioFactors 44:6, pages 539-547.
Crossref
Crossref
Aatur D. Singhi & Anirban Maitra. 2018. Pancreatic Cancer. Pancreatic Cancer
147
176
.
Max M. Tr?ger & Sameer A. Dhayat. (2017) Epigenetics of epithelial-to-mesenchymal transition in pancreatic carcinoma. International Journal of Cancer 141:1, pages 24-32.
Crossref
Crossref
Brian Quattrochi, Anushree Gulvady, David R. Driscoll, Makoto Sano, David S. Klimstra, Christopher E. Turner & Brian C. Lewis. (2017)
MicroRNAs of the
mir-17~92
cluster regulate multiple aspects of pancreatic tumor development and progression
. Oncotarget 8:22, pages 35902-35918.
Crossref
Crossref
Lei Xue, Xiying Yu, Xingran Jiang, Xin Deng, Linlin Mao, Liping Guo, Jinhu Fan, Qinqxia Fan, Liuxing Wang & Shih-Hsin Lu. (2016) TM4SF1 promotes the self-renewal of esophageal cancer stem-like cells and is regulated by miR-141. Oncotarget 8:12, pages 19274-19284.
Crossref
Crossref
Maria Rovithi, Amir Avan, Niccola Funel, Leticia G. Leon, Valentina E. Gomez, Thomas Wurdinger, Arjan W. Griffioen, Henk M. W. Verheul & Elisa Giovannetti. (2017) Development of bioluminescent chick chorioallantoic membrane (CAM) models for primary pancreatic cancer cells: a platform for drug testing. Scientific Reports 7:1.
Crossref
Crossref
Aatur D. Singhi & Anirban Maitra. 2017. Pancreatic Cancer. Pancreatic Cancer
1
30
.
Chi-Han Li, Zhangang Xiao, Joanna Hung-Man Tong, Ka-Fai To, Xiangdong Fang, Alfred SL Cheng & Yangchao Chen. (2017) EZH2 coupled with HOTAIR to silence MicroRNA-34a by the induction of heterochromatin formation in human pancreatic ductal adenocarcinoma. International Journal of Cancer 140:1, pages 120-129.
Crossref
Crossref
Marta Passadouro & Henrique Faneca. (2016) Managing Pancreatic Adenocarcinoma: A Special Focus in MicroRNA Gene Therapy. International Journal of Molecular Sciences 17:5, pages 718.
Crossref
Crossref
Oliver A. Kent, Joshua T. Mendell & Robert Rottapel. (2016) Transcriptional Regulation of miR-31 by Oncogenic KRAS Mediates Metastatic Phenotypes by Repressing RASA1. Molecular Cancer Research 14:3, pages 267-277.
Crossref
Crossref
Andre De Souza, Khadija Irfan Khawaja, Faisal Masud & Muhammad Wasif Saif. (2016) Metformin and pancreatic cancer: Is there a role?. Cancer Chemotherapy and Pharmacology 77:2, pages 235-242.
Crossref
Crossref
FEI MIAO, JINHAI ZHU, YANLIN CHEN, NANHONG TANG, XIAOQIAN WANG & XIUJIN LI. (2016) MicroRNA-183-5p promotes the proliferation, invasion and metastasis of human pancreatic adenocarcinoma cells. Oncology Letters 11:1, pages 134-140.
Crossref
Crossref
Juan-Fei Peng. (2016) Noncoding RNAs and pancreatic cancer. World Journal of Gastroenterology 22:2, pages 801.
Crossref
Crossref
Bárbara Alemar, Patrícia Izetti, Cleandra Gregório, Gabriel S. Macedo, Mauro Antonio Alves Castro, Alessandro Bersch Osvaldt, Ursula Matte & Patricia Ashton-Prolla. (2016) miRNA-21 and miRNA-34a Are Potential Minimally Invasive Biomarkers for the Diagnosis of Pancreatic Ductal Adenocarcinoma. Pancreas 45:1, pages 84-92.
Crossref
Crossref
Alexey Popov, Arpad Szabo & Václav Mandys. (2015) Small nucleolar RNA U91 is a new internal control for accurate microRNAs quantification in pancreatic cancer. BMC Cancer 15:1.
Crossref
Crossref
Satyanarayana Rachagani, Muzafar A. Macha, Melanie S. Menning, Parama Dey, Priya Pai, Lynette M. Smith, Yin-Yuan Mo & Surinder K. Batra. (2015) Changes in microRNA (miRNA) expression during pancreatic cancer development and progression in a genetically engineered KrasG12D;Pdx1-Cre mouse (KC) model. Oncotarget 6:37, pages 40295-40309.
Crossref
Crossref
Shahid G. Farid & Gareth Morris-Stiff. (2015) “OMICS” technologies and their role in foregut primary malignancies. Current Problems in Surgery 52:10, pages 409-441.
Crossref
Crossref
Ya-Zeng Huang, Jun Zhang, Hai-Yu Shao, Jin-Ping Chen & Hong-Ying Zhao. (2015) MicroRNA-191 promotes osteosarcoma cells proliferation by targeting checkpoint kinase 2. Tumor Biology 36:8, pages 6095-6101.
Crossref
Crossref
Shiv K Singh, Nai‐Ming Chen, Elisabeth Hessmann, Jens Siveke, Marlen Lahmann, Garima Singh, Nadine Voelker, Sophia Vogt, Irene Esposito, Ansgar Schmidt, Cornelia Brendel, Thorsten Stiewe, Jochen Gaedcke, Marco Mernberger, Howard C Crawford, William R Bamlet, Jin‐San Zhang, Xiao‐Kun Li, Thomas C Smyrk, Daniel D Billadeau, Matthias Hebrok, Albrecht Neesse, Alexander Koenig & Volker Ellenrieder. (2015)
Antithetical
NFAT
c1–Sox2 and p53–miR200 signaling networks govern pancreatic cancer cell plasticity
. The EMBO Journal 34:4, pages 517-530.
Crossref
Crossref
MAKOTO ABUE, MISA YOKOYAMA, RIE SHIBUYA, KEIICHI TAMAI, KAZUNORI YAMAGUCHI, IKURO SATO, NOBUYUKI TANAKA, SHIN HAMADA, TOORU SHIMOSEGAWA, KAZUO SUGAMURA & KENNICHI SATOH. (2015) Circulating miR-483-3p and miR-21 is highly expressed in plasma of pancreatic cancer. International Journal of Oncology 46:2, pages 539-547.
Crossref
Crossref
Bárbara AlemarCleandra GregórioPatricia Ashton-Prolla. (2015) miRNAs as Diagnostic and Prognostic Biomarkers in Pancreatic Ductal Adenocarcinoma and Its Precursor Lesions: A Review. Biomarker Insights 10, pages BMI.S27679.
Crossref
Crossref
Tereza Halkova, Romana Cuperkova, Marek Minarik & Lucie Benesova. (2015) MicroRNAs in Pancreatic Cancer: Involvement in Carcinogenesis and Potential Use for Diagnosis and Prognosis. Gastroenterology Research and Practice 2015, pages 1-11.
Crossref
Crossref
Ilaria Dando, Marco Cordani, Elisa Dalla Pozza, Giulia Biondani, Massimo Donadelli & Marta Palmieri. (2015) Antioxidant Mechanisms and ROS-Related MicroRNAs in Cancer Stem Cells. Oxidative Medicine and Cellular Longevity 2015, pages 1-13.
Crossref
Crossref
Anne E. Sarver, Lihua Li, Reena V. Kartha & Subbaya Subramanian. 2015. microRNA: Cancer. microRNA: Cancer
1
21
.
Bente Vilming Elgaaen, Ole Kristoffer Olstad, Kari Bente Foss Haug, Berit Brusletto, Leiv Sandvik, Anne Cathrine Staff, Kaare M Gautvik & Ben Davidson. (2014) Global miRNA expression analysis of serous and clear cell ovarian carcinomas identifies differentially expressed miRNAs including miR-200c-3p as a prognostic marker. BMC Cancer 14:1.
Crossref
Crossref
Hua Liu, Xuan-Fu Xu, Yan Zhao, Mao-Chun Tang, Ying-Qun Zhou, Jie Lu & Feng-Hou Gao. (2014) MicroRNA-191 promotes pancreatic cancer progression by targeting USP10. Tumor Biology 35:12, pages 12157-12163.
Crossref
Crossref
Hui-Chang Bi, Yu-Zhuo Pan, Jing-Xin Qiu, Kristopher W. Krausz, Fei Li, Caroline H. Johnson, Chang-Tao Jiang, Frank J. Gonzalez & Ai-Ming Yu. (2014) N-methylnicotinamide and nicotinamide N-methyltransferase are associated with microRNA-1291-altered pancreatic carcinoma cell metabolome and suppressed tumorigenesis. Carcinogenesis 35:10, pages 2264-2272.
Crossref
Crossref
Oliver A. Kent, Matthew N. McCall, Toby C. Cornish & Marc K. Halushka. (2014) Lessons from miR-143/145: the importance of cell-type localization of miRNAs. Nucleic Acids Research 42:12, pages 7528-7538.
Crossref
Crossref
Neha Nagpal & Ritu Kulshreshtha. (2014) miR-191: an emerging player in disease biology. Frontiers in Genetics 5.
Crossref
Crossref
Shing-Chun Tang. (2014) Novel therapeutic targets for pancreatic cancer. World Journal of Gastroenterology 20:31, pages 10825.
Crossref
Crossref
Yiwei Li, Dejuan Kong, Aamir Ahmad, Bin Bao & Fazlul H. Sarkar. 2014. MicroRNA Targeted Cancer Therapy. MicroRNA Targeted Cancer Therapy
199
217
.
Bin Bao, Asfar S. Azmi, Aamir Ahmad, Yiwei Li, Sanjeev Banerjee, Dejuan Kong, Shadan Ali & Fazlul H. Sarkar. 2014. MicroRNAs: Key Regulators of Oncogenesis. MicroRNAs: Key Regulators of Oncogenesis
295
320
.
Chin-Sheng Hung, Hui-Hsiung Liu, Jun-Jen Liu, Chi-Tai Yeh, Tung-Cheng Chang, Chih-Hsiung Wu, Yuan-Soon Ho, Po-Li Wei & Yu-Jia Chang. (2012) MicroRNA-200a and -200b Mediated Hepatocellular Carcinoma Cell Migration Through the Epithelial to Mesenchymal Transition Markers. Annals of Surgical Oncology 20:S3, pages 360-368.
Crossref
Crossref
Honor J Hugo, Lloyd Pereira, Randy Suryadinata, Yvette Drabsch, Thomas J Gonda, N P A Devika Gunasinghe, Cletus Pinto, Eliza TL Soo, Bryce JW van Denderen, Prue Hill, Robert G Ramsay, Boris Sarcevic, Donald F Newgreen & Erik W Thompson. (2013) Direct repression of MYB by ZEB1 suppresses proliferation and epithelial gene expression during epithelial-to-mesenchymal transition of breast cancer cells. Breast Cancer Research 15:6.
Crossref
Crossref
Yi Miao. (2013) hsa-miR-141 downregulates TM4SF1 to inhibit pancreatic cancer cell invasion and migration. International Journal of Oncology.
Crossref
Crossref
Qi Ling, Xiao Xu, Shu-Sen Zheng & Holger Kalthoff. (2013) The diversity between pancreatic head and body/tail cancers: clinical parameters and in vitro models. Hepatobiliary & Pancreatic Diseases International 12:5, pages 480-487.
Crossref
Crossref
Neha Nagpal, Hafiz M. Ahmad, Bhuvan Molparia & Ritu Kulshreshtha. (2013) MicroRNA-191, an estrogen-responsive microRNA, functions as an oncogenic regulator in human breast cancer. Carcinogenesis 34:8, pages 1889-1899.
Crossref
Crossref
Ang Li, Jun Yu, Haeryoung Kim, Christopher L. Wolfgang, Marcia Irene Canto, Ralph H. Hruban & Michael Goggins. (2013) MicroRNA Array Analysis Finds Elevated Serum miR-1290 Accurately Distinguishes Patients with Low-Stage Pancreatic Cancer from Healthy and Disease Controls. Clinical Cancer Research 19:13, pages 3600-3610.
Crossref
Crossref
Bin Bao, Aamir Ahmad, Asfar S. Azmi, Shadan Ali & Fazlul H. Sarkar. (2013) Overview of Cancer Stem Cells (CSCs) and Mechanisms of Their Regulation: Implications for Cancer Therapy. Current Protocols in Pharmacology 61:1.
Crossref
Crossref
O A Kent, K Fox-Talbot & M K Halushka. (2012) RREB1 repressed miR-143/145 modulates KRAS signaling through downregulation of multiple targets. Oncogene 32:20, pages 2576-2585.
Crossref
Crossref
Yong Huang, You Bing Yang, Xiao Hui Zhang, Xue Li Yu, Zhan Bin Wang & Xiang Chao Cheng. (2013) MicroRNA-21 gene and cancer. Medical Oncology 30:1.
Crossref
Crossref
Bin Bao, Anthony Oraha, Aamir Ahmad, Shadan Ali, Yiwei Li, Asfar S. Azmi, Sanjeev Banerjee & Fazlul H. Sarkar. 2013. Breast Cancer Metastasis and Drug Resistance. Breast Cancer Metastasis and Drug Resistance
117
142
.
Zainul Hasanali, August Stuart, Nelson Yee, Kamal Sharma & Elliot Epner. (2012) The Epigenetics of Gastrointestinal Malignancies. Current Colorectal Cancer Reports 8:4, pages 254-262.
Crossref
Crossref
PengXu Qian, Arindam Banerjee, Zheng-Sheng Wu, Xiao Zhang, Hong Wang, Vijay Pandey, Wei-Jie Zhang, Xue-Fei Lv, Sheng Tan, Peter E. Lobie & Tao Zhu. (2012) Loss of SNAIL Regulated miR-128-2 on Chromosome 3p22.3 Targets Multiple Stem Cell Factors to Promote Transformation of Mammary Epithelial Cells. Cancer Research 72:22, pages 6036-6050.
Crossref
Crossref
Kohei Nakata, Kenoki Ohuchida, Kazuhiro Mizumoto & Masao Tanaka. (2012) MicroRNA-10b is overexpressed in pancreatic cancer. Surgery 152:5, pages 938.
Crossref
Crossref
Adam E. Frampton, Jonathan Krell, Yaojun Zhang, Justin Stebbing, Leandro Castellano & Long R. Jiao. (2012) The role of miR-10b in metastatic pancreatic ductal adenocarcinoma. Surgery 152:5, pages 936-938.
Crossref
Crossref
Pankaj K. Singh, Randall E. Brand & Kamiya Mehla. (2012) MicroRNAs in pancreatic cancer metabolism. Nature Reviews Gastroenterology & Hepatology 9:6, pages 334-344.
Crossref
Crossref
Eeva M. Laurila, Saana Sandström, Laura M. Rantanen, Reija Autio & Anne Kallioniemi. (2012) Both inhibition and enhanced expression of miR‐31 lead to reduced migration and invasion of pancreatic cancer cells. Genes, Chromosomes and Cancer 51:6, pages 557-568.
Crossref
Crossref
Bin Bao, Zhiwei Wang, Shadan Ali, Aamir Ahmad, Asfar S. Azmi, Sanila H. Sarkar, Sanjeev Banerjee, Dejuan Kong, Yiwei Li, Shivam Thakur & Fazlul H. Sarkar. (2012) Metformin Inhibits Cell Proliferation, Migration and Invasion by Attenuating CSC Function Mediated by Deregulating miRNAs in Pancreatic Cancer Cells. Cancer Prevention Research 5:3, pages 355-364.
Crossref
Crossref
Seth B. Krantz, Mario A. Shields, Surabhi Dangi-Garimella, Hidayatullah G. Munshi & David J. Bentrem. (2012) Contribution of Epithelial-to-Mesenchymal Transition and Cancer Stem Cells to Pancreatic Cancer Progression. Journal of Surgical Research 173:1, pages 105-112.
Crossref
Crossref
Jun Yu, Ang Li, Seung-Mo Hong, Ralph H. Hruban & Michael Goggins. (2012) MicroRNA Alterations of Pancreatic Intraepithelial Neoplasias. Clinical Cancer Research 18:4, pages 981-992.
Crossref
Crossref
Nardin Samuel & Thomas J. Hudson. (2011) The molecular and cellular heterogeneity of pancreatic ductal adenocarcinoma. Nature Reviews Gastroenterology & Hepatology 9:2, pages 77-87.
Crossref
Crossref
Nigel B. Jamieson, Douglas C. Morran, Jennifer P. Morton, Asif Ali, Euan J. Dickson, C. Ross Carter, Owen J. Sansom, T.R. Jeffry Evans, Colin J. McKay & Karin A. Oien. (2012) MicroRNA Molecular Profiles Associated with Diagnosis, Clinicopathologic Criteria, and Overall Survival in Patients with Resectable Pancreatic Ductal Adenocarcinoma. Clinical Cancer Research 18:2, pages 534-545.
Crossref
Crossref
Bin Bao, Shadan Ali, Sanjeev Banerjee, Zhiwei Wang, Farah Logna, Asfar S. Azmi, Dejuan Kong, Aamir Ahmad, Yiwei Li, Subhash Padhye & Fazlul H. Sarkar. (2012) Curcumin Analogue CDF Inhibits Pancreatic Tumor Growth by Switching on Suppressor microRNAs and Attenuating EZH2 Expression. Cancer Research 72:1, pages 335-345.
Crossref
Crossref
Yinghua He, Ying Cui, Wei Wang, Jun Gu, Shicheng Guo, Kelong Ma & Xiaoying Luo. (2011) Hypomethylation of the hsa-miR-191 Locus Causes High Expression of hsa-miR-191 and Promotes the Epithelial-to-Mesenchymal Transition in Hepatocellular Carcinoma. Neoplasia 13:9, pages 841-IN23.
Crossref
Crossref
Ji Kon Ryu, Hanno Matthaei, Marco dal Molin, Seung-Mo Hong, Marcia I. Canto, Richard D. Schulick, Christopher Wolfgang, Michael G. Goggins, Ralph H. Hruban, Leslie Cope & Anirban Maitra. (2011) Elevated microRNA miR-21 Levels in Pancreatic Cyst Fluid Are Predictive of Mucinous Precursor Lesions of Ductal Adenocarcinoma. Pancreatology 11:3, pages 343-350.
Crossref
Crossref
Dipankar Pramanik, Nathaniel R. Campbell, Collins Karikari, Raghu Chivukula, Oliver A. Kent, Joshua T. Mendell & Anirban Maitra. (2011) Restitution of Tumor Suppressor MicroRNAs Using a Systemic Nanovector Inhibits Pancreatic Cancer Growth in Mice. Molecular Cancer Therapeutics 10:8, pages 1470-1480.
Crossref
Crossref
Audrey Vincent, Joseph Herman, Rich Schulick, Ralph H Hruban & Michael Goggins. (2011) Pancreatic cancer. The Lancet 378:9791, pages 607-620.
Crossref
Crossref
Audrey Vincent, Noriyuki Omura, Seung-Mo Hong, Andrew Jaffe, James Eshleman & Michael Goggins. (2011) Genome-Wide Analysis of Promoter Methylation Associated with Gene Expression Profile in Pancreatic Adenocarcinoma. Clinical Cancer Research 17:13, pages 4341-4354.
Crossref
Crossref
Seung-Mo Hong, Jason Y. Park, Ralph H. Hruban & Michael Goggins. (2011) Molecular Signatures of Pancreatic Cancer. Archives of Pathology & Laboratory Medicine 135:6, pages 716-727.
Crossref
Crossref
Bin Bao, Zhiwei Wang, Yiwei Li, Dejuan Kong, Shadan Ali, Sanjeev Banerjee, Aamir Ahmad & Fazlul H. Sarkar. (2011) The complexities of obesity and diabetes with the development and progression of pancreatic cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1815:2, pages 135-146.
Crossref
Crossref
Jun Hao, Shuyu Zhang, Yingqi Zhou, Xiangui Hu & Chenghao Shao. (2011) MicroRNA 483-3p suppresses the expression of DPC4/Smad4 in pancreatic cancer. FEBS Letters 585:1, pages 207-213.
Crossref
Crossref
Ioannis A Voutsadakis. (2011) Molecular predictors of gemcitabine response in pancreatic cancer. World Journal of Gastrointestinal Oncology 3:11, pages 153.
Crossref
Crossref
Emily J. Noonan, Robert F. Place & Long-Cheng Li. 2011. MicroRNAs in Cancer Translational Research. MicroRNAs in Cancer Translational Research
415
447
.
Oliver A. Kent, Raghu R. Chivukula, Michael Mullendore, Erik A. Wentzel, Georg Feldmann, Kwang H. Lee, Shu Liu, Steven D. Leach, Anirban Maitra & Joshua T. Mendell. (2010) Repression of the miR-143/145 cluster by oncogenic Ras initiates a tumor-promoting feed-forward pathway. Genes & Development 24:24, pages 2754-2759.
Crossref
Crossref
Seth B. Krantz, Mario A. Shields, Surabhi Dangi-Garimella, David J. Bentrem & Hidayatullah G. Munshi. (2010) Contribution of Epithelial-Mesenchymal Transition to Pancreatic Cancer Progression. Cancers 2:4, pages 2084-2097.
Crossref
Crossref
Harald J. Maier, Thomas Wirth & Hartmut Beug. (2010) Epithelial-Mesenchymal Transition in Pancreatic Carcinoma. Cancers 2:4, pages 2058-2083.
Crossref
Crossref
Simone Brabletz & Thomas Brabletz. (2010) The ZEB/miR‐200 feedback loop—a motor of cellular plasticity in development and cancer?. EMBO reports 11:9, pages 670-677.
Crossref
Crossref
Ulrich Wellner, Thomas Brabletz & Tobias Keck. (2010) ZEB1 in Pancreatic Cancer. Cancers 2:3, pages 1617-1628.
Crossref
Crossref
Yi Yang, Raghothama Chaerkady, Kumaran Kandasamy, Tai-Chung Huang, Lakshmi Dhevi N. Selvan, Sutopa B. Dwivedi, Oliver A. Kent, Joshua T. Mendell & Akhilesh Pandey. (2010) Identifying targets of miR-143 using a SILAC-based proteomic approach. Molecular BioSystems 6:10, pages 1873.
Crossref
Crossref